We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current NXEN market cap is 1.34M. The company's latest EPS is USD -0.0035 and P/E is -5.71.
Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -2.67M | -1.84M | -564k | -283k | -156k |
Net Income | -2.67M | -1.86M | -626k | -362k | -239k |
Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 23k | 26k | 125k | 43k | 4k |
Total Liabilities | 29k | 40k | 242k | 295k | 365k |
Total Equity | -6k | -14k | -117k | -252k | -361k |
Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -147k | -91k | -75k | -82k | -64k |
Investing | N/A | N/A | N/A | N/A | N/A |
Financing | 12k | 98k | 174k | N/A | 33k |
Market Cap | 1.34M |
Price to Earnings Ratio | -5.71 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 200 |
Price to Book Ratio | -3.74 |
Dividend Yield | - |
Shares Outstanding | 67.47M |
Average Volume (1 week) | 24.07k |
Average Volume (1 Month) | 22.54k |
52 Week Change | -21.96% |
52 Week High | 0.0495 |
52 Week Low | 0.011 |
Spread (Intraday) | 0.04 (73.54%) |
Company Name | Nexien BioPharma Inc (PK) |
Address |
16192 coastal highway lewes, delaware 19958 |
Website | https://nexienbiopharma.com |
Industry | drugs and proprietary-whsl (5122) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions